Всеволод Вячеславович Данилов

Всеволод Вячеславович Данилов

Auto-generated profile, based on publicly available information

Всеволод Вячеславович Данилов

N.N. Petrov National Medical Research Center of Oncology

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2020 in Cancer Urology
Verified
Journal Article
Open access
PDF file
NRN. A. Rubtsova
N. A. Rubtsova
AMA. V. Mishchenko
A. V. Mishchenko
VDV. V. Danilov
V. V. Danilov
GGG. A. Gulin
G. A. Gulin
BAB. Ya. Alekseev
B. Ya. Alekseev
AKAndrei Kaprin
Andrei Kaprin
Previously presented Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) system was developed on the basis of consensus that was achieved by the results of published studies containing expert and analytical conclusions. Numerous studies on PI-RADS v2, not only confirmed the importance of a unified system in the diagnosis of prostate cancer, but also revealed a number of limitations. In order to eliminate flaws of PI-RADS v2, a number of potential solutions were proposed. The PI-RADS Steering Committee recommended changes in PI-RADS v2, with maintaining the structure of sequence scoring and using these scores to obtain the final category. The updated version was published as PI-RADS v2.1 at the beginning of 2019. It is expected that the use of PI-RADS v2.1 will optimize and simplify the evaluation magnetic resonance imaging of prostate and reduce the number of interpretation errors. At the same time, it is necessary to continue further studies on the assessment of the clinical significance of this system when choosing a treatment strategy and monitoring patients with a high potentialfor the development

28 December 2022 in Medical Visualization
Verified
Journal Article
Open access
PDF file
ACA. V. Chernaya
A. V. Chernaya
RUR. Kh. Ulyanova
R. Kh. Ulyanova
SBS. S. Bagnenko
S. S. Bagnenko
ПКП. В. Криворотько
П. В. Криворотько
AAA. S. Artemyeva
A. S. Artemyeva
РУР. Х. Ульянова
Р. Х. Ульянова
Introduction. Differential diagnosis of some pathological processes in the breast is difficult on the background of dense breast tissue. This often leads to false conclusions and to late diagnosis of breast cancer (BC) or unreasonable biopsy in a benign process. 50% of breast cancers detected less than 12 months after elective mammography were associated with high density of breast tissue. An important advantage of contrast enhanced spectral mammography (CESM) is that it does not depend on the size of the lesions and the X-ray density of the breast tissue. Objective. To compare the diagnostic performance of CESM and digital mammography (DM) in detection of breast cancer in a group of women with dense breast tissue. Materials and methods. The data of 438 patients with suspected breast cancer examined from August 2018 to January 2021 were analyzed in the study. The mean age of women was 50 ± 11 years (from 21 to 86 years). In the study group 154 (35%) malignant and 284 (65%) benign lesions were identified. All lesions were histologically verified. Breast tissue density corresponded to types A and B in 161 patients and corresponded to C and D types in 277 patients according to the ACR classification. 154 cases of breast cancer were identified, including 49 patients with density A and B and 105 patients with density C and D types. Results. Sensitivity, specificity and overall accuracy of DM were 85.7%, 87.3%, 86.8%, respectively. Diagnostic performance of CESM significantly higher than of DM with sensitivity, specificity and accuracy of 96.8% (p < 0.001), 93.3% (p = 0.015), 94.5% (p < 0.001), respectively. CESM had high positive and negative predictive values of 88.7% (p = 0.012) and 98.1% (p < 0.001), which exceeded those of DM – 78.6% and 91.9%, respectively. The diagnostic performance of DM and CESM were comparable in women with normal breast density (types A and B according to ACR), but in patients with high breast density (types C and D according to ACR), CESM was significantly more sensitive in detecting breast cancer. Conclusion. Thus, diagnostic efficiency of CESM in detecting breast cancer significantly higher in comparison with digital mammography.

20 December 2021 in Tumors of female reproductive system
Verified
Journal Article
Open access
PDF file
ACA. V. Chyornaya
A. V. Chyornaya
RUR. Kh. Ulyanova
R. Kh. Ulyanova
ПКП. В. Криворотько
П. В. Криворотько
AAA. S. Artemyeva
A. S. Artemyeva
SBS. S. Bagnenko
S. S. Bagnenko
РУР. Х. Ульянова
Р. Х. Ульянова
Background. Breast cancer (BC) can be unifocal, multifocal, multicentric (MCBC) and bilateral according to number and localization of tumors. MCBC has different clinical and biological characteristics compared to unifocal BC, for example, a higher risk of lymph node involvement, a more aggressive natural history and a worse prognosis. Therefore, accurate diagnosis and detection of MCBC is one of the main tasks of imaging.Objective: to compare diagnostic accuracy of contrast enhanced spectral mammography (CESM) and digital mammography (DM) in the diagnosis of MCBC.Materials and methods. The study included 438 women with suspected BC. The results of DM and CESM were compared with the results of a pathomorphological study performed after surgery or biopsy to assess the effectiveness of imaging modalities. DM was performed for all women using a Senographe DS (GE, USA) unit. CESM was performed after intravenous injection of non-ionic contrast agents using injector with breast compression in the craniocaudal and mediolateral projections. The study was performed for both glands regardless of the location of the suspicious lesion in order to timely diagnose clinically asymptomatic bilateral cancer. The final diagnosis was made based on the results of the pathomorphological examination. MCBC was diagnosed when two or more tumors at a distance of 3 cm or more from each other were detected. Visualization of additional grouped calcifications of malignant type occupying a small portion of breast tissue (more than 15 pieces per 1 sq. cm) was considered as another mammographic sign of MCBC.Results. According to the pathomorphological examination BC was diagnosed in 154 (35 %) women out of 438 examined patients. MCBC was identified in 25 (16 %) of 154 patients. CESM was more effective than DM in detecting MCBC with sensitivity of 88.0 % vs 48.0 % (p = 0.002), accuracy of 92.2 % vs 90.9 %, negative predictive value of 97.6 % vs 90.8 % (p = 0.02), respectively. But the specificity was significantly higher in DM than in CESM – 99.2 % vs 93.0 % (p = 0.009), respectively, and the positive predictive value did not differ significantly (p = 0.12).Conclusion. CESM is a more sensitive method for diagnosing MCBC compared to DM with sensitivity of 88.0 % vs 48.0 %. The high negative predictive value of CESM (97.6 %) confirms the fact that this modality is an effective method for planning surgery and radiation therapy.

12 December 2019 in Tumors of female reproductive system
Verified
Journal Article
Open access
PDF file
ACA. V. Chernaya
A. V. Chernaya
PKP. I. Krzhivitskiy
P. I. Krzhivitskiy
ЕБЕ. А. Бусько
Е. А. Бусько
ПКП. В. Криворотько
П. В. Криворотько
AAA. S. Artemyeva
A. S. Artemyeva
SKS. V. Kanaev
S. V. Kanaev
Background. The development of effective methods for diagnosing multicentric breast cancer patients (BC) is of great clinical importance, because it determines the tactics of surgical and radiation treatment.The aim of study: to compare diagnostic accuracy of scintimammography (SMG), digital mammography (MMG) and ultrasound (US) in the diagnosis of multicentric BC.Materials and methods. 410 women with histologically confirmed BC were included in this analysis. SMG was performed with dual detector SPECT unit Forte (Philips, Netherlands). Mammographic digital images were obtained on Senographe DS unit (GE Healthcare, USA). In 319 of 410 evaluated women we were able to determine results of preoperative US with high-frequency (7—18 MHz), high resolution linear array transducer. The pathological report was used as the gold standard. Multicentric BC was defined as 2 or more distinct invasive tumors occupying more than one quadrant. Detection of additional grouped calcifications of malignant type occupying a small portion of breast tissue (more than 15 pieces per 1 sq. cm) was considered as another mammographic sign of multicentric BC.Results. According to histopathological examinations multicentric BC was diagnosed in 51 of 410patients. SMG was more effective than MMG in detecting multicentric BC: sensitivity — 84.3 % vs 54.9 % (p 0.001), specificity — 98 % vs 95.8 % (p = 0.02), accuracy — 96.3 % vs 90.7 % (p = 0.04), positive and negative predictive values — 86 % vs 65.1 % (p = 0.004) and 97.8 % vs 93.7 % (p = 0.01), respectively. Histologically multicentric BC was revealed in 44 of 319 women that had US of the breasts. Sensitivity, specificity, accuracy, positive and negative predictive values for US were 52.3 %, 94.5 %, 88.7 %, 60.5 % and 92.5 %, respectively. SMG significantly (p 0.001) outperformed US for all diagnostic characteristics. Combination of MMG and SMG characterized by increased sensitivity (94.1 %), 94.2 % specificity, 94.1 % accuracy and positive predictive value of only 69,6 %.Conclusions. SMG is significantly more sensitive (84.3 %) than MMG (54.9 %) and US (52.3 %) in detection of multicentric BC. High (86 %) positive predictive value of SMG advocates it as a tool for surgery and radiotherapy planning.

1 December 2022 in Tumors of female reproductive system
Verified
Journal Article
Open access
PDF file
NPN. S. Popova
N. S. Popova
SNS. N. Novikov
S. N. Novikov
PKP. I. Krzhivitskiy
P. I. Krzhivitskiy
LZL. A. Zhukova
L. A. Zhukova
ПКП. В. Криворотько
П. В. Криворотько
SKS. V. Kanaev
S. V. Kanaev
Background. The accurate and early diagnosis of breast cancer can improve efficacy of the treatment. The standard diagnostic methods such as mammography, ultrasound, and magnetic resonance tomography have a pivotal role in the detection of breast tumors, however, in some cases, they have low diagnostic accuracy. Mammoscintigraphy (MSG) / molecular breast imaging (MBI) with tumor-specific radiopharmacy 99mTc-Technetril in patients with breast cancer can considerably increase the accuracy of diagnosis. However, the diagnostic performance of MSG / MBI in the detection of different biological subtypes of breast cancer is still under investigation.Aim. To evaluate the accuracy of MSG / MBI with 99mTc-Technetril in diagnosis of different biological subtypes of breast cancer.Materials and methods. The analysis included the results of MSG / MBI of 1080 patients (2154 mammary glands), who were examined for suspected breast cancer. MSG / MBI were performed 5–15 min after intravenous injection into the vein of one of the feet of 370–740 MBq of tumor-specific radiopharmacy 99mTc-Technetril. Examinations performed from 2007–2020 was carried out on the emission computed tomography Forte (Philips); since 2020 the molecular visualization has been providing on the special gamma-camera Discovery NM750b (General Electric). The obtained data were evaluated by 2 experienced radiologists. Verification of changes in breasts was provided by morphological examination (1060 cases) or dynamic observation.Results. The sensitivity, specificity and overall accuracy of MSG / MBI were 90 %, 98 %, 95 % correspondingly. When diagnosing tumors with a diameter of up to 10 mm, the sensitivity of MSG / MBI was decreased to 83 %. In patients with various biological subtypes, the sensitivity of MSG / MBI was as follows: luminal A – 88 %; luminal B– – 91 %; luminal B+ – 92 %; triple negative – 93 %; HER2-positive – 96 %. The intensity of tumor uptake depended on the biological subtype of breast cancer. The average values of the 99mTc-Technetril uptake coefficient were as follows: luminal A – 1.59; luminal B– – 1.71; luminal B+ – 1.95; triple negative – 1.93; HER2-positive – 2.22.Conclusion. Retrospective analysis indicate high diagnostic performance of MSG / MBI: sensitivity – 90 %, specificity – 98 %, accuracy – 95 %. There are significant differences in the intensity of 99mTc-Technetril accumulation in tumors in patients with different biological subtypes of breast cancer (p = 0.01–0.004). MSG / MBI characterized by significant differences in the sensitivity in the diagnosis of luminal A and HER2+ breast cancer subtypes: 88 % and 96 %, respectively (p = 0.02).

1 March 2020 in Voprosy onkologii
Verified
Journal Article
Open access
PDF file
RURoksana Ulyanova
Roksana Ulyanova
ACA. Chernaya
A. Chernaya
ПКПетр Криворотько
Петр Криворотько
SNSergey Novikov
Sergey Novikov
SKSergey Kanaev
Sergey Kanaev
VDVsevolod Danilov
Vsevolod Danilov
Dual-energy contrast-enhanced spectral mammography (CESM) is a new promising method for visualizing pathological changes in breast, which combines digital mammography and a functional assessment of vascularization using intravenous contrast ehnancement. According to accumulated experience CESM is well tolerated by patients and is similar to magnetic resonance imaging with dynamic contrast enhancement (MRI with DCE), but at the same time, CESM is more affordable and can be performed in patients with contraindications for MRI. However, few studies have been conducted to evaluate the role of CESM. In the world literature, interpretation of contrast images is based only on the degree of accumulation of the contrast agent, but we propose a more detailed assessment of the structure of the hypervascular lesions by highlighting the contrast enhancement patterns. Objective: to determine the diagnostic effectiveness of CESM using the contrast enhancement patterns in malignant and benign lesions. Materials and methods. 239 women with suspicious for breast cancer lesions were examined from August 2018 to December 2019. The mean age of the women was 51 years. 322 lesions were revealed, 149 (46.3%) were malignant, 173 (53.7%) were benign. All lesions were histologically confirmed. As a result of the analysis of our data, 9 types of contrast enhancement patterns were distinguished: reticulate, granular, annular, diffuse-spherical, lacunar, cloud-like, heterogeneous-annular, point, cotton-like. Results. Using an additional diagnostic feature - contrast enhancement patterns in lesions, increased the sensitivity of CESM from 91.3% to 98.0% (p=0.26), specificity from 80.3% to 93, 6% (p=0.013), accuracy from 85.4 to 95.7% (p=0.004) in comparison with using of only one feature of contrast enhancement intensity in the differential diagnosis of malignant and benign lesions. Conclusion: thus, this approach of interpreting subtraction images allows to increase the efficiency of CESM in diagnosis of breast cancer. Введение. Контрастная спектральная двухэнергетическая маммография (КСДМ) является новым перспективным методом визуализации патологических изменений молочной железы (МЖ), который сочетает в себе стандартное маммографическое исследование и функциональную оценку васкуляризации с помощью внутривенного контрастирования. Накопленный опыт свидетельствует, что исследование хорошо переносится пациентами и похоже на магнитно-резонансную томографию с динамическим контрастным усилением (МРТ с ДКУ), но при этом КСДМ доступнее и может быть выполнен пациентам, которым МРТ противопоказана. Однако, опыт использования методики по-прежнему ограничен, и требует дальнейшего исследования. В мировой литературе описание интерпретации контрастных изображений базируется только на степени накопления контрастного препарата, нами же предлагается более детальная оценка структуры гиперваскулярного образования с помощью выделения типов накопления. Целью исследования являлось определение диагностической эффективности КСДМ с использованием типов накопления контрастного препарата (КП) злокачественными и доброкачественными образованиями. Материалы и методы. В исследовании проанализированы данные 239 пациенток, обследованных за период с августа 2018 по декабрь 2019 г. в связи с подозрением на наличие злокачественного новообразования МЖ. Средний возраст женщин составил 51 год. В исследуемой группе выявлено 322 образования, из которых 149 (46,3%) - злокачественные, 173 (53,7%) - доброкачественные. Все выявленные образования гистологически верифицированы. В результате анализа полученных данных было выделено 9 типов накопления контрастного вещества: сетчатый, зернистый, кольцевидный, диффузно-сферический, лакунарный, облаковидный, неоднородно-кольцевидный, точечный, хлопковидный. Результаты. При использовании дополнительного диагностического критерия - типа накопления КП образованиями - чувствительность КСДМ в сравнении с анализом только интенсивности накопления КП повышалась с 91,3% до 98,0% (р=0,26), специфичность с 80,3% до 93,6% (р=0,013), точность с 85,4% до 95,7% (р=0,004) при дифференциальной диагностике злокачественных и доброкачественных образований. Заключение. Таким...